Session » Healthcare Disparities in Rheumatology Poster III

Date: Monday, November 18, 2024

Time: 10:30AM-12:30PM

Meeting: ACR Convergence 2024

10:30AM-12:30PM: Abstract Number: 1917

Access to Rheumatology Care near Indian Health Service Hospitals for American Indian Communities

10:30AM-12:30PM: Abstract Number: 1920

Admixture Mapping and Gene-Based Analysis Identifies Rare Variants in Genes in the IL-13 and TGFβ Signaling Pathways in African Americans with Systemic Sclerosis

10:30AM-12:30PM: Abstract Number: 1910

Appointment Adherence: Impact of Health Portal Access, Letters, Phone Calls and Text Message Reminders in Underserved Population

10:30AM-12:30PM: Abstract Number: 1907

Community-Engaged Curriculum Development Using Racial Justice and Biomedical Lenses to Address COVID-19 Vaccine Hesitancy in Black Individuals with Rheumatologic Conditions

10:30AM-12:30PM: Abstract Number: 1921

Devastating Morbidity and Mortality Rates in the Hmong Population with a Diagnosis of Gout Who Had a COVID-19 Infection

10:30AM-12:30PM: Abstract Number: 1927

Ethnic and Racial Minorities in Clinical Trials for Autoimmune Connective Tissue Disease Therapeutic Agents

10:30AM-12:30PM: Abstract Number: 1918

Exploring the Childhood Opportunity Index and Distance to Care in a Cohort of Children with Rheumatic Disease

10:30AM-12:30PM: Abstract Number: 1912

Greater Glucocorticoid and Less Biologic/Targeted Therapy Use in Midwest PsA Patients Despite Prevalent Comorbidity

10:30AM-12:30PM: Abstract Number: 1913

Health Literacy and Disease, Clinical, Functional and Management Outcomes in Inflammatory Arthritis: A Systematic Literature Review

10:30AM-12:30PM: Abstract Number: 1916

Healthcare Disparities and Clinical Outcomes in Cardiac Sarcoidosis. a Retrospective Cohort Study

10:30AM-12:30PM: Abstract Number: 1911

Improving Healthcare Access in Underserved Brooklyn Communities: A Comprehensive Multispecialty Patient Navigator Program

10:30AM-12:30PM: Abstract Number: 1922

Insights into Rheumatology Practice in Uganda

10:30AM-12:30PM: Abstract Number: 1908

Male Sex, Medical Comorbidity and Post-procedure Complications Are Associated with Higher In-hospital Mortality After Primary Total Knee Arthroplasty for Osteoarthritis

10:30AM-12:30PM: Abstract Number: 1915

Patient-reported Difficulties Regarding Reproductive Health Discussions in an Urban Outpatient Setting

10:30AM-12:30PM: Abstract Number: 1919

Patient-reported Social Risk Factor Screening Among Rheumatology Outpatients

10:30AM-12:30PM: Abstract Number: 1926

Race/ethnicity Is Associated with Disease Severity in Pediatric Patients with ANCA-associated Vasculitis Hospitalized in the United States

10:30AM-12:30PM: Abstract Number: 1914

Racial and Ethnic Differences in the Prevalence of Disease Features in Systemic Sclerosis

10:30AM-12:30PM: Abstract Number: 1924

Racial and Gender Disparities in Psoriatic Arthritis Clinical Trials

10:30AM-12:30PM: Abstract Number: 1909

Racial Disparities in Ocular Complications of Systemic Rheumatic Diseases: A Retrospective Cross-Sectional Study

10:30AM-12:30PM: Abstract Number: 1923

Social Determinants of Health Documentation and Prevalence Among Rheumatology Patients Seen in a Southern Medical Center

10:30AM-12:30PM: Abstract Number: 1925

Use of Geocoded Social Deprivation Indices to Understand Health Disparities in Pediatric Rheumatology

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].